BLAIR WILLIAM & CO/IL - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$1,085,000
-60.4%
68,141
-48.4%
0.01%
-57.9%
Q4 2017$2,742,000
+233.6%
131,941
+130.1%
0.02%
+216.7%
Q3 2017$822,000
-34.8%
57,341
-21.3%
0.01%
-33.3%
Q2 2017$1,261,000
+94.3%
72,866
+58.4%
0.01%
+80.0%
Q1 2017$649,000
+4.3%
46,001
+7.3%
0.01%
-16.7%
Q4 2016$622,000
-37.8%
42,868
+5.2%
0.01%
-33.3%
Q3 2016$1,000,000
+25.3%
40,734
+2.8%
0.01%
+28.6%
Q2 2016$798,000
-16.9%
39,634
+8.5%
0.01%
-22.2%
Q1 2016$960,000
-72.7%
36,520
+5.5%
0.01%
-72.7%
Q4 2015$3,519,000
+231.7%
34,625
+481.9%
0.03%
+266.7%
Q3 2015$1,061,000
-97.5%
5,950
-96.9%
0.01%
-85.9%
Q2 2015$42,695,000
+11.2%
192,195
-0.6%
0.06%
+8.5%
Q1 2015$38,400,000
+737.7%
193,335
+503.5%
0.06%
+742.9%
Q4 2014$4,584,000
-33.6%
32,034
-39.1%
0.01%
-41.7%
Q3 2014$6,905,000
+3.1%
52,633
-0.9%
0.01%
+9.1%
Q2 2014$6,696,000
-9.8%
53,093
-5.7%
0.01%
-8.3%
Q1 2014$7,425,000
+29.2%
56,328
+15.0%
0.01%
+33.3%
Q4 2013$5,747,000
+12.4%
48,962
-0.1%
0.01%0.0%
Q3 2013$5,112,000
+21.4%
49,007
+0.1%
0.01%
+12.5%
Q2 2013$4,212,00048,9420.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2013
NameSharesValueWeighting ↓
Capital Analysts, LLC 7,350$439,309,0000.18%
GOLDMAN SACHS GROUP INC 2,996,127$179,078,0000.07%
MUFG Americas Holdings Corp 52,285$3,125,0000.06%
Zurcher Kantonalbank (Zurich Cantonalbank) 22,936$1,367,0000.05%
GOLDMAN SACHS GROUP INC 419,100$25,050,0000.01%
AQR Capital Management 35,829$2,141,0000.01%
HSBC HOLDINGS PLC 33,669$2,009,0000.01%
GOLDMAN SACHS GROUP INC 147,000$8,786,0000.00%
NOMURA HOLDINGS INC 6,000$359,0000.00%
Twin Tree Management, LP 455$27,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders